EU Cystic Fibrosis Market, Market Segmented, by Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, and CFTR Modulators), and by Route of Administration (Oral and Inhaled) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138249
- Pages: 200
-
Format:
Report Overview
The EU Cystic Fibrosis Market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 13.8% during the forecast period
Cystic fibrosis is a hereditary disorder, which majorly affects lungs and other body parts such as pancreas, liver, and kidney. It is caused by the mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This gene is located in chromosome number 7, and is responsible for the regulation of sweat, mucus, and body secretions
Market Drivers
Increase in governmental support for innovation and rise in funding of projects for R&D of various cystic fibrosis drugs will boost the market growth. High cost of the cystic fibrosis treatment and introduction of generic drugs will hinder the growth of the market
1. EU Cystic Fibrosis Market Overview
A. Market Size
2. EU Cystic Fibrosis Market Growth Drivers and Restraints
A. Increase in governmental support for innovation and rise in funding of projects for R&D of various cystic fibrosis drugs
B. High cost of the cystic fibrosis treatment and introduction of generic drugs
3. EU Cystic Fibrosis Market Segmentation
A. By Drug Class
I. Pancreatic Enzyme Supplements
II. Mucolytic, Bronchodilators
III. CFTR Modulators
B. By Route of Administration
I. Oral
II. Inhaled
4. EU Cystic Fibrosis Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Genentech, Inc., Company overview, Product & Services, Strategies & Financials
B. Novartis AG, Company overview, Product & Services, Strategies & Financials
C. Gilead Sciences, Inc, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
